A major advance in cancer research is arising with the use of mini-antibodies to reactivate dysfunctional p53. This crucial cancer inhibitor protein is frequently disabled in many forms of tumors, resulting https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research